These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 7621254)

  • 1. Antisense approaches to cancer gene therapy.
    Mercola D; Cohen JS
    Cancer Gene Ther; 1995 Mar; 2(1):47-59. PubMed ID: 7621254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of antisense oligonucleotides in oncology.
    Pierga JY; Magdelenat H
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects for antisense therapy].
    Maekawa T
    Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy.
    Thomas SM; Zeng Q; Dyer KF; Suscovich TJ; Kanter PM; Whalen JD; Watkins SF; Grandis JR
    Cancer Gene Ther; 2003 Jul; 10(7):518-28. PubMed ID: 12833132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.
    Zhang WW; Roth JA
    In Vivo; 1994; 8(5):755-69. PubMed ID: 7727723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of antisense oligonucleotides.
    Sharma HW; Narayanan R
    Bioessays; 1995 Dec; 17(12):1055-63. PubMed ID: 8634067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide therapeutics: clothing the emperor.
    Gewirtz AM
    Curr Opin Mol Ther; 1999 Jun; 1(3):297-306. PubMed ID: 11713794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
    Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
    Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines.
    Raschellà G; Negroni A; Skorski T; Pucci S; Nieborowska-Skorska M; Romeo A; Calabretta B
    Cancer Res; 1992 Aug; 52(15):4221-6. PubMed ID: 1638535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
    Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
    Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
    Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not nonsense but antisense--applications of antisense oligonucleotides in different fields of medicine.
    Oberbauer R
    Wien Klin Wochenschr; 1997 Jan; 109(2):40-6. PubMed ID: 9123943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Basics of antisense oligonucleotide therapy and current therapeutical strategies in urology].
    Kausch I; Böhle A
    Aktuelle Urol; 2003 Dec; 34(7):458-68. PubMed ID: 14655082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
    Laird AD; Brown PI; Fausto N
    Cancer Res; 1994 Aug; 54(15):4224-32. PubMed ID: 8033155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
    Hung WC; Huang JS; Chuang LY
    Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo.
    Kang CS; Zhang ZY; Jia ZF; Wang GX; Qiu MZ; Zhou HX; Yu SZ; Chang J; Jiang H; Pu PY
    Cancer Gene Ther; 2006 May; 13(5):530-8. PubMed ID: 16410821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model.
    Kausch I; Jiang H; Brocks C; Bruderek K; Krüger S; Sczakiel G; Jocham D; Böhle A
    Eur Urol; 2004 Jul; 46(1):118-24; discussion 124-5. PubMed ID: 15183557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosomal protein P2: a potential molecular target for antisense therapy of human malignancies.
    Gardner-Thorpe J; Ito H; Ashley SW; Whang EE
    Anticancer Res; 2003; 23(6C):4549-60. PubMed ID: 14981896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense oligonucleotide technology in the development of cancer therapeutics.
    Tseng BY; Brown KD
    Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.